<DOC>
	<DOCNO>NCT01299571</DOCNO>
	<brief_summary>An open label , multi-centre , non-interventional post-marketing surveillance monitor safety and/or efficacy AVODART administer Korean BPH patient accord prescribe information</brief_summary>
	<brief_title>AVODART ( Dutasteride ) Post-marketing Surveillance ( PMS )</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Dutasteride</mesh_term>
	<criteria>The Korean BPH Patients administrate dutasteride accord prescribe information woman child adolescent . patient hypersensitivity dutasteride , 5alpha reductase inhibitor , excipients .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>